NIH-funded research R01 grant

Predicting acute rejection in children after heart transplant

Official title: Predictive modeling of acute rejection in pediatric heart transplant recipients

Funded at Vanderbilt University Medical Center · NIH-11364137 · Data updated 2026-11-12

A study to improve how doctors predict if a child who has had a heart transplant will have acute rejection using noninvasive blood markers and advanced heart MRI analysis.

More Transplant research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startJuly 15, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$619,026
NIH project number5R01HL164995-05
Project IDNIH-11364137 on NIH RePORTER

Who could benefit from this research

Could help

Children who have received a heart transplant and are monitored for rejection.

Less likely to help

Patients without access to MRIs or blood biomarker testing may not benefit directly.

What this research studies

This project aims to reduce the need for invasive heart biopsies in kids by using blood tests and MRI data to detect early signs of rejection. Researchers will combine donor DNA fragments in blood and microRNA with sophisticated image analysis of MRI scans to spot patterns that signal rejection. The team plans to develop user-friendly methods that clinicians can apply in real time to guide treatment decisions. If successful, these tools could lower the number of biopsies and improve safety for pediatric patients.

Why it matters

Potential benefit: If successful, patients could receive fewer invasive biopsies and earlier, more precise treatment for rejection.

How similar studies have gone: Early noninvasive signals of rejection have shown promise, but this approach seeks to combine biomarkers with imaging in children specifically.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Soslow, Jonathan Harvey — Vanderbilt University Medical Center
  • Study coordinator: Soslow, Jonathan Harvey

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.